Senior DirectorCenter for Drug Policy
(R6) GLP-1 Agonists for Weight Management within the Commercially Insured Market: How Real-world Evidence Can Inform Benefit Design
Wednesday, October 16, 20244:15 PM – 5:30 PM PT